# CAPLYTA
> **NDA209500** · New Drug Application · Sponsor: INTRA-CELLULAR · Approved 2019-12-20
## Drug
- **FDA Application Number:** NDA209500
- **Application type:** New Drug Application
- **Brand name:** CAPLYTA
- **Generic name:** LUMATEPERONE
- **Active ingredients:** LUMATEPERONE TOSYLATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** INTRA-CELLULAR
- **Manufacturer:** Intra-Cellular Therapies, Inc
- **First approval:** 2019-12-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209500)
---
*MORVS · CC0 1.0*